NCT03292328 is a NA clinical trial of Yoga in Breast Cancer, sponsored by Memorial Sloan Kettering Cancer Center.

Who is sponsoring NCT03292328?

NCT03292328 is sponsored by Memorial Sloan Kettering Cancer Center.

What drugs are being tested in NCT03292328?

Interventions in NCT03292328: Yoga, Wait List Control.

What condition does NCT03292328 study?

NCT03292328 studies Breast Cancer, Peripheral Neuropathy, Gynecologic Cancer.

Is NCT03292328 still recruiting?

NCT03292328 is currently completed. Last updated 13 May 2025.

Last reviewed 2025-05-13 · How we verify

NCT03292328

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Yoga for Symptoms of Nerve Damage Caused by Chemotherapy

Completed NA Last updated 13 May 2025

What this trial tests

NA trial testing Yoga in Breast Cancer in 51 participants. Completed in 15 September 2020.

Timeline

18 September 2017

Primary endpoint
15 September 2020

15 September 2020

Quick facts

Lead sponsor	Memorial Sloan Kettering Cancer Center
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	supportive care
Enrollment	51
Start date	18 September 2017
Primary completion	15 September 2020
Estimated completion	15 September 2020
Sites	2 locations across United States

Drugs / interventions tested

Yoga
Wait List Control

Conditions studied

Breast Cancer — all drugs for Breast Cancer →
Peripheral Neuropathy — all drugs for Peripheral Neuropathy →
Gynecologic Cancer — all drugs for Gynecologic Cancer →

Sponsor

Memorial Sloan Kettering Cancer Center — full company profile →

Who can join

18 and older, any sex, with Breast Cancer or Peripheral Neuropathy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Some types of chemotherapy used to treat breast cancer can cause damage to nerves with symptoms like tingling, numbness, muscle weakness, and pain in the hands and feet that can last and can affect functioning. The purpose of this study is to find out the effects of yoga on reducing symptoms caused by such nerve damage.

Publications & conference data

4 peer-reviewed publications reference this trial (live from Europe PMC):

Yoga for Chemotherapy-Induced Peripheral Neuropathy and Fall Risk: A Randomized Controlled Trial.
Bao T, Zhi I, Baser R, Hooper M, et al · · 2020 · cited 41× · PMID 33225208 · DOI 10.1093/jncics/pkaa048
Yoga for cancer survivors with chemotherapy-induced peripheral neuropathy: Health-related quality of life outcomes.
Zhi WI, Baser RE, Zhi LM, Talukder D, et al · · 2021 · cited 23× · PMID 34213086 · DOI 10.1002/cam4.4098
Characterization of chemotherapy-induced peripheral neuropathy using patient-reported outcomes and quantitative sensory testing.
Zhi WI, Baser RE, Kwon A, Chen C, et al · · 2021 · cited 20× · PMID 33507480 · DOI 10.1007/s10549-020-06079-2
Yoga for fatigue in people with cancer.
Messer S, Oeser A, Wagner C, Wender A, et al · · 2025 · cited 2× · PMID 40421669 · DOI 10.1002/14651858.cd015520

Verify or expand the search:

Other trials of Yoga

Trials testing the same drug.

NCT06559852 — The Impact of Yoga on Endometriosis-Related Pain · NA · recruiting
NCT07485790 — The Effects of Yoga on Pregnant Women · NA · recruiting
NCT07480174 — Effects of Tai Chi and Yoga on Flexibility, Anxiety, and Sleep Quality in Women · NA · recruiting
NCT06949007 — Yoga for Persistent Post-Surgical Pain (PPSP) · NA · recruiting
NCT07415850 — The Effect of a Four-Week Hatha Yoga Intervention to Improve Quality of Life, Anxiety, and Depressive Symptoms in Indivi · NA · not yet recruiting

Other recruiting trials for Breast Cancer

Currently open trials in the same condition.

NCT06148038 — CBD for Breast Cancer Primary Tumors · Phase 1 · recruiting
NCT07405801 — A Phase II Study Evaluating the Efficacy and Safety of Inavolisib Plus Ribociclib Plus Fulvestrant Versus Placebo Plus R · Phase 2 · recruiting
NCT07285993 — Detection and Outcomes in Metastatic Invasive Lobular Breast Cancer Through Novel F-18 FAP PET · Phase 2 · recruiting
NCT07510698 — Same-Day Awake Mastectomy With Immediate Breast Reconstruction for Patients With Breast Cancer · NA · recruiting
NCT06768931 — Biolosion Combined Standard Neoadjuvant Therapy to Treat Triple-negative Breast Cancer · Phase 2 · recruiting

Other Memorial Sloan Kettering Cancer Center trials

Trials by the same sponsor.

NCT07566377 — Cord Blood Transplantation in Children and Young Adults With Blood Cancer · Phase 2 · recruiting
NCT07507643 — A Study of Methylprednisolone in People Having Liver Surgery · Phase 3 · recruiting
NCT07483307 — A Study of the Impact of Endocrine Therapy on Surgical Outcomes in People With Breast Cancer · Phase 2 · recruiting
NCT07459673 — HERizon-Breast: A ctDNA-Guided Adaptive Study of Sequential Anti-HER2 Therapies and CNS Prophylaxis to Induce Long-Term · Phase 2 · recruiting
NCT07449195 — A Study Comparing Two Optical Coherence Tomography Devices in People With Ocular Tumors · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03292328 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Memorial Sloan Kettering Cancer Center
Last refreshed: 13 May 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03292328.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing